Imugene Ltd (ASX:IMU)

APAC company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IMU

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IMU

  • Market CapAUD0.000m
  • SymbolASX:IMU
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU000000IMU9

Company Profile

Imugene Ltd specializes is a clinical-stage immuno-oncology company. Its product includes HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being Research, Development, and Commercialisation of oncolytic immunotherapies.Imugene Ltd specializes is a pharmaceutical company focused on developing HER2 +ve gastric and breast cancer vaccines. Its product includes HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.

Latest IMU news

Currently there for this company. Visit our news hub for other news .